Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Growth hormone response to clonidine administration for evaluation of autonomic dysfunction in multiple sclerosis patients.
Third ventricular enlargement in early stages of multiple sclerosis is a predictor of motor and neuropsychological deficits: a cross-sectional study.
Synaptic plasticity in multiple sclerosis and in experimental autoimmune encephalomyelitis.
[Locomotive syndrome and Frailty. Vitamin D and Frailty].
Anti-aquaporin 4 antibody-positive acute disseminated encephalomyelitis.
The habenula and iron metabolism in cerebral mouse models of multiple sclerosis.
Dietary Vitamin D and Its Metabolites Non-Genomically Stabilize the Endothelium.
Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses.
We-Measure: Toward a low-cost portable posturography for patients with multiple sclerosis using the commercial Wii balance board.
Pharmacology and Structure of P2Y Receptors.
Laquinimod (ABR-215062) for the treatment of relapsing multiple sclerosis.
A comparison of linear and nonlinear stability parameters in different clinical forms of multiple sclerosis.
Whole-brain atrophy: ready for implementation into clinical decision-making in multiple sclerosis?
RAD001 (everolimus) attenuates experimental autoimmune neuritis by inhibiting the mTOR pathway, elevating Akt activity and polarizing M2 macrophages.
Anatomical brain connectivity can assess cognitive dysfunction in multiple sclerosis.
[Multiple sclerosis: a comprehensive treatment and rehabilitation].
Headaches in multiple sclerosis patients might imply an inflammatorial process.
Determining disease intervention strategies using spatially resolved simulations.
Longitudinal Follow-up of a Cohort of Patients with Incidental Abnormal Magnetic Resonance Imaging Findings at Presentation and Their Risk of Developing Multiple Sclerosis.
Vision and vision-related outcome measures in multiple sclerosis.
Prostacyclin Prevents Pericyte Loss and Demyelination Induced by Lysophosphatidylcholine in the Central Nervous System.
Cognitive and patient-reported outcomes in adults with pediatric-onset multiple sclerosis.
Chronic inflammatory demyelinating polyneuropathy in children: a report of four patients with variable relapsing courses.
Altered expression of myelin-associated inhibitors and their receptors after traumatic brain injury in the mouse.
Age-dependent redistribution and hypersialylation of the central myelin paranodal loop membrane protein Opalin in the mouse brain.
Pages
« first
‹ previous
…
631
632
633
634
635
636
637
638
639
…
next ›
last »